WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 15-Jul-2018 (data as of 15-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'7901 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 10'6991 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 3'912  3'925  3'952  3'992  4'046  4'722  5'410  5'018 
Births 52  54  55  57  58  57  91  93 
Surviving infants 51  53  55  56  57  55  87  89 
Pop. less than 5 years 266  271  275  279  284  287  465  425 
Pop. less than 15 years 750  744  739  739  742  1'068  1'345  1'281 
Female 15-49 years 904  916  933  959  989  1'225  1'334  1'310 

Number of reported cases

(Click for retrospective incidence data for Georgia)
Diphtheria
ChartChart
  28 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  94  14  431  3'188  7'872  50 
Mumps
ChartChart
  28  46  50  55  52  2'646 
Pertussis
ChartChart
  280  120  176  94  115  84 
Polio*
ChartChart
 
Rubella
ChartChart
  11  100  149  224  428 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Georgia)
Vaccine year result method % card seen                                                
BCG 1998  92  EPI   86  96  98  96  96  95  95 
DTP1 1998  87  EPI   86  98  97  97  99*  99*  99 
DTP3 1998  80  EPI   86  91  92  94  91  93  98 
DTP4          89  84  87  90 
IPV1          98  97  10 
HepB_BD          94  94  93  95  80 
HepB3          91  92  94  91  96  55 
Hib3          91  92  87  91  96 
JapEnc         
MCV1          95  93  96  92  97  97 
MCV2          90  85  91  87  89 
MenA         
PCV1          96  94  99*  10 
PCV2          91  92  90 
PCV3          80  75  16 
Pol3 1998  80  EPI   86  91  92  91  91  94  98 
Rota1          81  79  80  77  74 
RotaC          76  75  72  69  56 
RCV1          95  93  96  92  97 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Georgia)
BCG
ChartChart
  96  98  96  96  95  95 
DTP1
ChartChart
  98  97  97  99  99  89 
DTP3
ChartChart
  91  92  94  91  93  80 
HepB3
ChartChart
  91  92  94  91  96  55 
HepB_BD
ChartChart
  94  94  93  95  80 
Hib3
ChartChart
  91  92  87  91  96 
MCV1
ChartChart
  95  93  96  92  97  73 
MCV2
ChartChart
  90  85  91  87  89 
PCV3
ChartChart
  80  75  16 
Pol3
  91  92  91  91  94  81 
RCV1
ChartChart
  95  93  96  92  97 
RotaC
ChartChart
  76  75  72  69  41 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 65  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 71
From 80 to 89% 20
From 50 to 79% 9
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 0-5 days; Yes
DT 5 years; Yes
DTaPHibHepBIPV 2, 3, 4 months; Yes
DTaPHibHepIPV 2, 3, 4 months; Yes
DTwP 18 months; Yes
HepB_Pediatric 24 hours; Yes
HPV 9-10 years; +6 months; No December 2017-2019 demo project; females living in select regions/cities
Influenza_Adult Yes elderly, adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities, other risk groups
Influenza_Pediatric 6-59 months; Yes and children with chronic illness from 5-18 years
MMR 12 months; 5 years; Yes
OPV 18 months; 5 years; Yes
Pneumo_conj 2, 3, 12 months; Yes
Rotavirus 2, 3 months; Yes
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2021  2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2012-2016 
Nº of districts with microplans that include activities to raise immunization coverage number 65  65  65  65  65  65  65 

System performance

Total Nº districts in country number 65  65  65  65  65  65  65 
Nº districts with DTP3 coverage >=80% number 59  52  58  61  61  59  62 
% of districts with DTP3 coverage >=80% From 0 to 100% 91  80  89  94  94  91  95 
Nº districts with measles (MCV1) coverage >=95% number 40  40  46  32  41  31  35 
% of districts with MCV1 coverage >=95% From 0 to 100% 62  62  71  49  63  48  54 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 97  89  93  77  49  38  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 

Sources

 1  "The 2018 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.